Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment: An open study

A. Romigi, A. Cervellino, M. G. Marciani, F. Izzi, R. Massoud, M. Corona, F. Torelli, S. Zannino, E. Uasone, F. Placidi

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Few data are available on cognitive and psychiatric effects of topiramate (TPM) monotherapy in migraine. Twenty patients affected by migraine were treated with TPM monotherapy. At the same time, twenty control subjects were selected. A comprehensive neuropsychological and behavioural battery of tests were performed at baseline (T0), at titration (T1) and in maintenance period (T2). Topiramate serum levels were also investigated at T1 and T2. On comparison with the control group, no cognitive and psychiatric differences were detected at baseline. A significant reduction of word fluency score (P <0.05) was evident after TPM treatment, both at T1 and T2. No patient developed psychiatric adverse events. TPM induced an impairment of verbal fluency and no psychiatric adverse events, demonstrating selective negative cognitive profile in migraine therapy. Slow titration, low doses, lack of previous psychiatric disorders and/or familial history may explain our data.

Original languageEnglish
Pages (from-to)190-195
Number of pages6
JournalEuropean Journal of Neurology
Volume15
Issue number2
DOIs
Publication statusPublished - Feb 2008

Fingerprint

Migraine Disorders
Psychiatry
Therapeutics
History
Maintenance
topiramate
Control Groups
Serum

Keywords

  • Cognition
  • Migraine
  • Psychiatric effects
  • Topiramate

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment : An open study. / Romigi, A.; Cervellino, A.; Marciani, M. G.; Izzi, F.; Massoud, R.; Corona, M.; Torelli, F.; Zannino, S.; Uasone, E.; Placidi, F.

In: European Journal of Neurology, Vol. 15, No. 2, 02.2008, p. 190-195.

Research output: Contribution to journalArticle

Romigi, A, Cervellino, A, Marciani, MG, Izzi, F, Massoud, R, Corona, M, Torelli, F, Zannino, S, Uasone, E & Placidi, F 2008, 'Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment: An open study', European Journal of Neurology, vol. 15, no. 2, pp. 190-195. https://doi.org/10.1111/j.1468-1331.2007.02033.x
Romigi, A. ; Cervellino, A. ; Marciani, M. G. ; Izzi, F. ; Massoud, R. ; Corona, M. ; Torelli, F. ; Zannino, S. ; Uasone, E. ; Placidi, F. / Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment : An open study. In: European Journal of Neurology. 2008 ; Vol. 15, No. 2. pp. 190-195.
@article{788f15c145e6478d9fa77b8378af50cb,
title = "Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment: An open study",
abstract = "Few data are available on cognitive and psychiatric effects of topiramate (TPM) monotherapy in migraine. Twenty patients affected by migraine were treated with TPM monotherapy. At the same time, twenty control subjects were selected. A comprehensive neuropsychological and behavioural battery of tests were performed at baseline (T0), at titration (T1) and in maintenance period (T2). Topiramate serum levels were also investigated at T1 and T2. On comparison with the control group, no cognitive and psychiatric differences were detected at baseline. A significant reduction of word fluency score (P <0.05) was evident after TPM treatment, both at T1 and T2. No patient developed psychiatric adverse events. TPM induced an impairment of verbal fluency and no psychiatric adverse events, demonstrating selective negative cognitive profile in migraine therapy. Slow titration, low doses, lack of previous psychiatric disorders and/or familial history may explain our data.",
keywords = "Cognition, Migraine, Psychiatric effects, Topiramate",
author = "A. Romigi and A. Cervellino and Marciani, {M. G.} and F. Izzi and R. Massoud and M. Corona and F. Torelli and S. Zannino and E. Uasone and F. Placidi",
year = "2008",
month = "2",
doi = "10.1111/j.1468-1331.2007.02033.x",
language = "English",
volume = "15",
pages = "190--195",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "2",

}

TY - JOUR

T1 - Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment

T2 - An open study

AU - Romigi, A.

AU - Cervellino, A.

AU - Marciani, M. G.

AU - Izzi, F.

AU - Massoud, R.

AU - Corona, M.

AU - Torelli, F.

AU - Zannino, S.

AU - Uasone, E.

AU - Placidi, F.

PY - 2008/2

Y1 - 2008/2

N2 - Few data are available on cognitive and psychiatric effects of topiramate (TPM) monotherapy in migraine. Twenty patients affected by migraine were treated with TPM monotherapy. At the same time, twenty control subjects were selected. A comprehensive neuropsychological and behavioural battery of tests were performed at baseline (T0), at titration (T1) and in maintenance period (T2). Topiramate serum levels were also investigated at T1 and T2. On comparison with the control group, no cognitive and psychiatric differences were detected at baseline. A significant reduction of word fluency score (P <0.05) was evident after TPM treatment, both at T1 and T2. No patient developed psychiatric adverse events. TPM induced an impairment of verbal fluency and no psychiatric adverse events, demonstrating selective negative cognitive profile in migraine therapy. Slow titration, low doses, lack of previous psychiatric disorders and/or familial history may explain our data.

AB - Few data are available on cognitive and psychiatric effects of topiramate (TPM) monotherapy in migraine. Twenty patients affected by migraine were treated with TPM monotherapy. At the same time, twenty control subjects were selected. A comprehensive neuropsychological and behavioural battery of tests were performed at baseline (T0), at titration (T1) and in maintenance period (T2). Topiramate serum levels were also investigated at T1 and T2. On comparison with the control group, no cognitive and psychiatric differences were detected at baseline. A significant reduction of word fluency score (P <0.05) was evident after TPM treatment, both at T1 and T2. No patient developed psychiatric adverse events. TPM induced an impairment of verbal fluency and no psychiatric adverse events, demonstrating selective negative cognitive profile in migraine therapy. Slow titration, low doses, lack of previous psychiatric disorders and/or familial history may explain our data.

KW - Cognition

KW - Migraine

KW - Psychiatric effects

KW - Topiramate

UR - http://www.scopus.com/inward/record.url?scp=38349111455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38349111455&partnerID=8YFLogxK

U2 - 10.1111/j.1468-1331.2007.02033.x

DO - 10.1111/j.1468-1331.2007.02033.x

M3 - Article

C2 - 18217888

AN - SCOPUS:38349111455

VL - 15

SP - 190

EP - 195

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 2

ER -